Table 3 Efficacy of vaccines against clade 2.3.4.4 and clade 2.3.2.1 H5 highly pathogenic avian influenza viruses in chickens.

From: Influenza viral vectors expressing two kinds of HA proteins for bivalent vaccines against clade 2.3.4.4 and clade 2.3.2.1 H5 HPAIVs

Vaccine group

Challenge virus

Mean HI titer 21 days after immunization (log2)

Virus shedding (EID50/ml)

Survival

Day 3 p.c.a

Day 5 p.c.

Oropharyngeal

cloacal

Oropharyngeal

cloacal

PR8-H5-NS1(73)H5

FJ/5

8.6 ± 0.6

0/10

0/10

0/10

0/10

10/10

JS/7

5.4 ± 0.5

0/10

0/10

0/10

0/10

10/10

PR8-2344H5 + PR8-2321H5

FJ/5

8.8 ± 0.9

0/10

0/10

0/10

0/10

10/10

JS/7

8.4 ± 0.5

0/10

0/10

0/10

0/10

10/10

PR8-2344H5

FJ/5

8.9 ± 0.4

0/10

0/10

0/10

0/10

10/10

JS/7

0.8 ± 0.4

4/4 (4.2 ± 0.5)

4/4 (4.4 ± 0.4)

NAb

NA

0/10

Control

FJ/5

<1

4/4 (4.5 ± 0.6)

4/4 (4.8 ± 0.5)

NA

NA

0/10

JS/7

<1

4/4 (4.1 ± 0.3)

4/4 (4.5 ± 0.4)

NA

NA

0/10

  1. apc: post challenge.
  2. bNA: not applicable due to death of chickens.